Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_assertion type Assertion NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_head.
- NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_assertion description "[In colorectal cancer (CRC), evidence shows that expanding RAS testing to analyze more mutations may better predict benefit from anti-EGFR therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_provenance.
- NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_assertion evidence source_evidence_literature NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_provenance.
- NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_assertion SIO_000772 25410095 NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_provenance.
- NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_assertion wasDerivedFrom befree-2016 NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_provenance.
- NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_assertion wasGeneratedBy ECO_0000203 NP1238628.RAiCt-6cF45LQycf6xrwhLTxzQWLsrcxaZxp854Pk-oUY130_provenance.